Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07529509 · ClinicalTrials.gov registry record · NA
Abriendo Caminos: Engaging Latinos
A NA study, sponsored by Yale University.
- Recruiting
- Registry status
- NA
- Development phase
- 30
- Enrollment target
NCT07529509: Recruiting NA study, sponsored by Yale University.
NCT07529509 is a NA study that is actively recruiting participants, run by Yale University. The registered enrollment target is 30 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07529509, a NA study, is actively recruiting participants, sponsored by Yale University.
- RECRUITING
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to learn if a culturally responsive peer-delivered motivational interviewing intervention can enhance mental health treatment engagement in Latinos with serious mental illness. The main questions it aims to answer are: * How feasible is it to recruit 30 Latinos with serious mental illness into a 6 week treatment engagement intervention? * How acceptable is the intervention to Latinos with serious mental illness? Participants will: * Receive six sixty-minute sessions * Complete weekly measures, along with pre-, post-, 30-day, and 60-day post-intervention assessments
Primary Outcome
The average number of participants recruited to participate in the study
Interventions
- BEHAVIORAL Culturally responsive motivational interviewing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2026-07 |
| Est. Completion | 2027-08 |
| Phase | NA |
What NCT07529509 shows while recruiting
NCT07529509 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 1 intervention - of which Culturally responsive motivational interviewing is the first listed.
NCT07529509 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07529509 about?
NCT07529509 is a clinical study titled "Abriendo Caminos: Engaging Latinos". The goal of this clinical trial is to learn if a culturally responsive peer-delivered motivational interviewing intervention can enhance mental health treatment engagement in Latinos with serious mental illness. The main questions it aims to answer are: * How feasible is it to recruit 30 Latinos wi...
What is the current status of trial NCT07529509?
This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2026-07. Estimated completion is 2027-08.
What interventions are being tested in trial NCT07529509?
The interventions under investigation include: Culturally responsive motivational interviewing (BEHAVIORAL).
Who is sponsoring clinical trial NCT07529509?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07529509's enrollment target sits among peer trials
30 1593rd of 2000 higher than 299 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia